CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

INMBInmune Bio, Inc.

NASDAQ · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Last close $1.95 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Market cap$54.12M
CountryUSA
RECENT INSIDER TRADES
  • 2026-07-07 · Juda Scott (Director) · OTHER
  • 2026-07-07 · Lowdell Mark William (Chief Scientific Officer) · OTHER
  • 2026-07-07 · Moss David J (Chief Executive Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders89
Shares held6,543,208
Value$17.50M
Percent of shares outstanding23.58%
As of quarter end2026-06-30
RECENT NEWS
  • INmune Bio to attend 2026 Maxim Growth Summit
  • INmune Bio says rdeB drug nears regulatory filings
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS